E37: Errik Anderson on Co-Founding 20 Biotech Startups Cumulatively Worth $10B+
Errik Anderson sits down with David Weisburd to discuss Pro-noia, the potential of the biotech industry, and the 82VS Seed Fund investment approach. They discuss practicing Pro-noia, the value of building a portfolio of relationships, and the idea of a forever company. (0:00) Introduction to Errik Anderson and his…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from How I Invest with David Weisburd
See all episodes →
E433: AlphaSense’s Chris Ackerson on AI, the Future of Finance & Finding Alpha
E432: $24 Billion Investor on Private Credit, the Psychology of Winning & Fear of Failure
E431: Marty Kausas on AI, Trillion Dollar Startups & Founder Psychology
Similar episodes from other shows
More like How I Invest with David Weisburd →
EP 32: AI Discovers Drugs: The 2026 Clinical Trial Moment for AI in Biotech
D.A. Wallach Explains Why Biotech VC Is So Different
🔬Beyond AlphaFold: How Boltz is Open-Sourcing the Future of Drug Discovery
EP 27: AI Revolutionizing Drug Discovery (2023 - 2025)
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.